Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1099 entries
Sorted by: Best Match Show Resources per page
Editorial.

Bioorganic & medicinal chemistry letters

Boger DL.
PMID: 26343827
Bioorg Med Chem Lett. 2015 Nov 01;25(21):4713. doi: 10.1016/j.bmcl.2015.08.082. Epub 2015 Sep 01.

No abstract available.

Cite
Boger DL. Editorial. Bioorg Med Chem Lett. 2015;25(21):4713doi: 10.1016/j.bmcl.2015.08.082.
Boger, D. L. (2015). Editorial. Bioorganic & medicinal chemistry letters, 25(21), 4713. https://doi.org/10.1016/j.bmcl.2015.08.082
Boger, Dale L. "Editorial." Bioorganic & medicinal chemistry letters vol. 25,21 (2015): 4713. doi: https://doi.org/10.1016/j.bmcl.2015.08.082
Boger DL. Editorial. Bioorg Med Chem Lett. 2015 Nov 01;25(21):4713. doi: 10.1016/j.bmcl.2015.08.082. Epub 2015 Sep 01. PMID: 26343827.
Copy Download .nbib Format: NLM
Retraction notice to 'Design and synthesis of CHAP31, trapoxin B and HC-toxin based bicyclic tetrapeptides disulfide as potent histone deacetylase inhibitors' [Bioorg Med Chem 22 (2014) 3850-3855].

Bioorganic & medicinal chemistry

[No authors listed]
PMID: 26425745
Bioorg Med Chem. 2015 Aug 01;23(15):5078. doi: 10.1016/j.bmc.2015.06.057.

No abstract available.

Cite
Retraction notice to 'Design and synthesis of CHAP31, trapoxin B and HC-toxin based bicyclic tetrapeptides disulfide as potent histone deacetylase inhibitors' [Bioorg Med Chem 22 (2014) 3850-3855]. Bioorg Med Chem. 2015;23(15):5078doi: 10.1016/j.bmc.2015.06.057.
(2015). Retraction notice to 'Design and synthesis of CHAP31, trapoxin B and HC-toxin based bicyclic tetrapeptides disulfide as potent histone deacetylase inhibitors' [Bioorg Med Chem 22 (2014) 3850-3855]. Bioorganic & medicinal chemistry, 23(15), 5078. https://doi.org/10.1016/j.bmc.2015.06.057
"Retraction notice to 'Design and synthesis of CHAP31, trapoxin B and HC-toxin based bicyclic tetrapeptides disulfide as potent histone deacetylase inhibitors' [Bioorg Med Chem 22 (2014) 3850-3855]." Bioorganic & medicinal chemistry vol. 23,15 (2015): 5078. doi: https://doi.org/10.1016/j.bmc.2015.06.057
Retraction notice to 'Design and synthesis of CHAP31, trapoxin B and HC-toxin based bicyclic tetrapeptides disulfide as potent histone deacetylase inhibitors' [Bioorg Med Chem 22 (2014) 3850-3855]. Bioorg Med Chem. 2015 Aug 01;23(15):5078. doi: 10.1016/j.bmc.2015.06.057. PMID: 26425745.
Copy Download .nbib Format: NLM
Corrigendum to "Antiplasmodial phloroglucinol derivatives from Syncarpia glomulifera" [Bioorg. Med. Chem. 24 (2016) 2544-2548].

Bioorganic & medicinal chemistry

Su Q, Dalal S, Goetz M, Cassera MB, Kingston DGI.
PMID: 28285928
Bioorg Med Chem. 2017 Apr 01;25(7):2294. doi: 10.1016/j.bmc.2017.02.062. Epub 2017 Mar 09.

No abstract available.

Cite
Su Q, Dalal S, Goetz M, et al. Corrigendum to "Antiplasmodial phloroglucinol derivatives from Syncarpia glomulifera" [Bioorg. Med. Chem. 24 (2016) 2544-2548]. Bioorg Med Chem. 2017;25(7):2294doi: 10.1016/j.bmc.2017.02.062.
Su, Q., Dalal, S., Goetz, M., Cassera, M. B., & Kingston, D. G. I. (2017). Corrigendum to "Antiplasmodial phloroglucinol derivatives from Syncarpia glomulifera" [Bioorg. Med. Chem. 24 (2016) 2544-2548]. Bioorganic & medicinal chemistry, 25(7), 2294. https://doi.org/10.1016/j.bmc.2017.02.062
Su, Qingxi, et al. "Corrigendum to "Antiplasmodial phloroglucinol derivatives from Syncarpia glomulifera" [Bioorg. Med. Chem. 24 (2016) 2544-2548]." Bioorganic & medicinal chemistry vol. 25,7 (2017): 2294. doi: https://doi.org/10.1016/j.bmc.2017.02.062
Su Q, Dalal S, Goetz M, Cassera MB, Kingston DGI. Corrigendum to "Antiplasmodial phloroglucinol derivatives from Syncarpia glomulifera" [Bioorg. Med. Chem. 24 (2016) 2544-2548]. Bioorg Med Chem. 2017 Apr 01;25(7):2294. doi: 10.1016/j.bmc.2017.02.062. Epub 2017 Mar 09. PMID: 28285928.
Copy Download .nbib Format: NLM
Synthetic approaches to the 2014 new drugs.

Bioorganic & medicinal chemistry

Flick AC, Ding HX, Leverett CA, Kyne RE, Liu KK, Fink SJ, O'Donnell CJ.
PMID: 27020685
Bioorg Med Chem. 2016 May 01;24(9):1937-80. doi: 10.1016/j.bmc.2016.03.004. Epub 2016 Mar 09.

New drugs introduced to the market every year represent privileged structures for particular biological targets. These new chemical entities (NCEs) provide insight into molecular recognition and also serve as leads for designing future new drugs. This annual review covers...

Cite
Flick AC, Ding HX, Leverett CA, et al. Synthetic approaches to the 2014 new drugs. Bioorg Med Chem. 2016;24(9):1937-80doi: 10.1016/j.bmc.2016.03.004.
Flick, A. C., Ding, H. X., Leverett, C. A., Kyne, R. E., Liu, K. K., Fink, S. J., & O'Donnell, C. J. (2016). Synthetic approaches to the 2014 new drugs. Bioorganic & medicinal chemistry, 24(9), 1937-80. https://doi.org/10.1016/j.bmc.2016.03.004
Flick, Andrew C, et al. "Synthetic approaches to the 2014 new drugs." Bioorganic & medicinal chemistry vol. 24,9 (2016): 1937-80. doi: https://doi.org/10.1016/j.bmc.2016.03.004
Flick AC, Ding HX, Leverett CA, Kyne RE, Liu KK, Fink SJ, O'Donnell CJ. Synthetic approaches to the 2014 new drugs. Bioorg Med Chem. 2016 May 01;24(9):1937-80. doi: 10.1016/j.bmc.2016.03.004. Epub 2016 Mar 09. PMID: 27020685.
Copy Download .nbib Format: NLM
Highly efficient method for .

Bioorganic & medicinal chemistry

Choi MH, Shim HE, Yun SJ, Kim HR, Mushtaq S, Lee CH, Park SH, Choi DS, Lee DE, Byun EB, Jang BS, Jeon J.
PMID: 27134118
Bioorg Med Chem. 2016 Apr 19; doi: 10.1016/j.bmc.2016.04.029. Epub 2016 Apr 19.

In this report, we present a rapid and highly efficient method for radioactive iodine labeling of trans-cyclooctene group conjugated biomolecules using inverse-electron-demand Diels-Alder reaction. Radioiodination reaction of the tetrazine structure was carried out using the stannylated precursor 2 to...

Cite
Choi MH, Shim HE, Yun SJ, et al. Highly efficient method for . Bioorg Med Chem. 2016;doi: 10.1016/j.bmc.2016.04.029.
Choi, M. H., Shim, H. E., Yun, S. J., Kim, H. R., Mushtaq, S., Lee, C. H., Park, S. H., Choi, D. S., Lee, D. E., Byun, E. B., Jang, B. S., & Jeon, J. (2016). Highly efficient method for . Bioorganic & medicinal chemistry, . https://doi.org/10.1016/j.bmc.2016.04.029
Choi, Mi Hee, et al. "Highly efficient method for ." Bioorganic & medicinal chemistry vol. (2016). doi: https://doi.org/10.1016/j.bmc.2016.04.029
Choi MH, Shim HE, Yun SJ, Kim HR, Mushtaq S, Lee CH, Park SH, Choi DS, Lee DE, Byun EB, Jang BS, Jeon J. Highly efficient method for . Bioorg Med Chem. 2016 Apr 19; doi: 10.1016/j.bmc.2016.04.029. Epub 2016 Apr 19. PMID: 27134118.
Copy Download .nbib Format: NLM
Corrigendum to "Structural features underlying raloxifene's biophysical interaction with bone matrix" [Bioorg. Med. Chem. 24 (2016) 759-767].

Bioorganic & medicinal chemistry

Bivi N, Hu H, Chavali B, Chalmers MJ, Reutter CT, Durst GL, Riley A, Sato M, Allen MR, Burr DB, Dodge JA.
PMID: 27544045
Bioorg Med Chem. 2016 Sep 15;24(18):4516. doi: 10.1016/j.bmc.2016.07.014. Epub 2016 Jul 14.

No abstract available.

Cite
Bivi N, Hu H, Chavali B, et al. Corrigendum to "Structural features underlying raloxifene's biophysical interaction with bone matrix" [Bioorg. Med. Chem. 24 (2016) 759-767]. Bioorg Med Chem. 2016;24(18):4516doi: 10.1016/j.bmc.2016.07.014.
Bivi, N., Hu, H., Chavali, B., Chalmers, M. J., Reutter, C. T., Durst, G. L., Riley, A., Sato, M., Allen, M. R., Burr, D. B., & Dodge, J. A. (2016). Corrigendum to "Structural features underlying raloxifene's biophysical interaction with bone matrix" [Bioorg. Med. Chem. 24 (2016) 759-767]. Bioorganic & medicinal chemistry, 24(18), 4516. https://doi.org/10.1016/j.bmc.2016.07.014
Bivi, Nicoletta, et al. "Corrigendum to "Structural features underlying raloxifene's biophysical interaction with bone matrix" [Bioorg. Med. Chem. 24 (2016) 759-767]." Bioorganic & medicinal chemistry vol. 24,18 (2016): 4516. doi: https://doi.org/10.1016/j.bmc.2016.07.014
Bivi N, Hu H, Chavali B, Chalmers MJ, Reutter CT, Durst GL, Riley A, Sato M, Allen MR, Burr DB, Dodge JA. Corrigendum to "Structural features underlying raloxifene's biophysical interaction with bone matrix" [Bioorg. Med. Chem. 24 (2016) 759-767]. Bioorg Med Chem. 2016 Sep 15;24(18):4516. doi: 10.1016/j.bmc.2016.07.014. Epub 2016 Jul 14. PMID: 27544045.
Copy Download .nbib Format: NLM
Corrigendum to "Assessing the oral bioavailability of difluorosialic acid prodrugs, potent viral neuraminidase inhibitors, using a snapshot PK screening assay" [Bioorg. Med. Chem. Lett. 25 (2015) 2505-2509].

Bioorganic & medicinal chemistry letters

Arns S, Tan J, Sun S, Galey A, Zisman N, Ross F, Udechukwu J, Dercho S, Gusti V, Paquette J, Wennekes T, Webb M, Bourque E, Withers SG, Liggins R.
PMID: 27381085
Bioorg Med Chem Lett. 2016 Jul 02; doi: 10.1016/j.bmcl.2016.06.068. Epub 2016 Jul 02.

No abstract available.

Cite
Arns S, Tan J, Sun S, et al. Corrigendum to "Assessing the oral bioavailability of difluorosialic acid prodrugs, potent viral neuraminidase inhibitors, using a snapshot PK screening assay" [Bioorg. Med. Chem. Lett. 25 (2015) 2505-2509]. Bioorg Med Chem Lett. 2016;doi: 10.1016/j.bmcl.2016.06.068.
Arns, S., Tan, J., Sun, S., Galey, A., Zisman, N., Ross, F., Udechukwu, J., Dercho, S., Gusti, V., Paquette, J., Wennekes, T., Webb, M., Bourque, E., Withers, S. G., & Liggins, R. (2016). Corrigendum to "Assessing the oral bioavailability of difluorosialic acid prodrugs, potent viral neuraminidase inhibitors, using a snapshot PK screening assay" [Bioorg. Med. Chem. Lett. 25 (2015) 2505-2509]. Bioorganic & medicinal chemistry letters, . https://doi.org/10.1016/j.bmcl.2016.06.068
Arns, Steve, et al. "Corrigendum to "Assessing the oral bioavailability of difluorosialic acid prodrugs, potent viral neuraminidase inhibitors, using a snapshot PK screening assay" [Bioorg. Med. Chem. Lett. 25 (2015) 2505-2509]." Bioorganic & medicinal chemistry letters vol. (2016). doi: https://doi.org/10.1016/j.bmcl.2016.06.068
Arns S, Tan J, Sun S, Galey A, Zisman N, Ross F, Udechukwu J, Dercho S, Gusti V, Paquette J, Wennekes T, Webb M, Bourque E, Withers SG, Liggins R. Corrigendum to "Assessing the oral bioavailability of difluorosialic acid prodrugs, potent viral neuraminidase inhibitors, using a snapshot PK screening assay" [Bioorg. Med. Chem. Lett. 25 (2015) 2505-2509]. Bioorg Med Chem Lett. 2016 Jul 02; doi: 10.1016/j.bmcl.2016.06.068. Epub 2016 Jul 02. PMID: 27381085.
Copy Download .nbib Format: NLM
Corrigendum to "Role of a gitogenin-type steroidal saponin (3-O-β-d-glucopyranosyl (1→2)-β-d-glucopyranosyl (1→4)-β-d-galactopyranoside-25R, 5α-spirostane-2α,3β-diol), isolated from the leaves of Malvastrum coromandelianum in regulating thyrotoxicosis in rats" [Bioorg. Med. Chem. Lett. 26 (2016) 4804-4807].

Bioorganic & medicinal chemistry letters

Panda S, Kar A.
PMID: 28365194
Bioorg Med Chem Lett. 2017 May 15;27(10):2238. doi: 10.1016/j.bmcl.2017.03.048. Epub 2017 Mar 30.

No abstract available.

Cite
Panda S, Kar A. Corrigendum to "Role of a gitogenin-type steroidal saponin (3-O-β-d-glucopyranosyl (1→2)-β-d-glucopyranosyl (1→4)-β-d-galactopyranoside-25R, 5α-spirostane-2α,3β-diol), isolated from the leaves of Malvastrum coromandelianum in regulating thyrotoxicosis in rats" [Bioorg. Med. Chem. Lett. 26 (2016) 4804-4807]. Bioorg Med Chem Lett. 2017;27(10):2238doi: 10.1016/j.bmcl.2017.03.048.
Panda, S., & Kar, A. (2017). Corrigendum to "Role of a gitogenin-type steroidal saponin (3-O-β-d-glucopyranosyl (1→2)-β-d-glucopyranosyl (1→4)-β-d-galactopyranoside-25R, 5α-spirostane-2α,3β-diol), isolated from the leaves of Malvastrum coromandelianum in regulating thyrotoxicosis in rats" [Bioorg. Med. Chem. Lett. 26 (2016) 4804-4807]. Bioorganic & medicinal chemistry letters, 27(10), 2238. https://doi.org/10.1016/j.bmcl.2017.03.048
Panda, Sunanda, and Kar, Anand. "Corrigendum to "Role of a gitogenin-type steroidal saponin (3-O-β-d-glucopyranosyl (1→2)-β-d-glucopyranosyl (1→4)-β-d-galactopyranoside-25R, 5α-spirostane-2α,3β-diol), isolated from the leaves of Malvastrum coromandelianum in regulating thyrotoxicosis in rats" [Bioorg. Med. Chem. Lett. 26 (2016) 4804-4807]." Bioorganic & medicinal chemistry letters vol. 27,10 (2017): 2238. doi: https://doi.org/10.1016/j.bmcl.2017.03.048
Panda S, Kar A. Corrigendum to "Role of a gitogenin-type steroidal saponin (3-O-β-d-glucopyranosyl (1→2)-β-d-glucopyranosyl (1→4)-β-d-galactopyranoside-25R, 5α-spirostane-2α,3β-diol), isolated from the leaves of Malvastrum coromandelianum in regulating thyrotoxicosis in rats" [Bioorg. Med. Chem. Lett. 26 (2016) 4804-4807]. Bioorg Med Chem Lett. 2017 May 15;27(10):2238. doi: 10.1016/j.bmcl.2017.03.048. Epub 2017 Mar 30. PMID: 28365194.
Copy Download .nbib Format: NLM
Corrigendum to "Investigation of the structure activity relationship of flufenamic acid derivatives at the human TRESK channel K2P18.1" [Bioorg. Med. Chem. Lett. 26 (2016) 4919-4924].

Bioorganic & medicinal chemistry letters

Monteillier A, Loucif A, Omoto K, Stevens EB, Lainez S, Saintot PP, Cao L, Pryde DC.
PMID: 28320618
Bioorg Med Chem Lett. 2017 May 01;27(9):2082. doi: 10.1016/j.bmcl.2017.02.063. Epub 2017 Mar 17.

No abstract available.

Cite
Monteillier A, Loucif A, Omoto K, et al. Corrigendum to "Investigation of the structure activity relationship of flufenamic acid derivatives at the human TRESK channel K2P18.1" [Bioorg. Med. Chem. Lett. 26 (2016) 4919-4924]. Bioorg Med Chem Lett. 2017;27(9):2082doi: 10.1016/j.bmcl.2017.02.063.
Monteillier, A., Loucif, A., Omoto, K., Stevens, E. B., Lainez, S., Saintot, P. P., Cao, L., & Pryde, D. C. (2017). Corrigendum to "Investigation of the structure activity relationship of flufenamic acid derivatives at the human TRESK channel K2P18.1" [Bioorg. Med. Chem. Lett. 26 (2016) 4919-4924]. Bioorganic & medicinal chemistry letters, 27(9), 2082. https://doi.org/10.1016/j.bmcl.2017.02.063
Monteillier, Aymeric, et al. "Corrigendum to "Investigation of the structure activity relationship of flufenamic acid derivatives at the human TRESK channel K2P18.1" [Bioorg. Med. Chem. Lett. 26 (2016) 4919-4924]." Bioorganic & medicinal chemistry letters vol. 27,9 (2017): 2082. doi: https://doi.org/10.1016/j.bmcl.2017.02.063
Monteillier A, Loucif A, Omoto K, Stevens EB, Lainez S, Saintot PP, Cao L, Pryde DC. Corrigendum to "Investigation of the structure activity relationship of flufenamic acid derivatives at the human TRESK channel K2P18.1" [Bioorg. Med. Chem. Lett. 26 (2016) 4919-4924]. Bioorg Med Chem Lett. 2017 May 01;27(9):2082. doi: 10.1016/j.bmcl.2017.02.063. Epub 2017 Mar 17. PMID: 28320618.
Copy Download .nbib Format: NLM
Retraction notice to 'Corrigendum to "3-Benzhydryl-4-piperidones as novel neurokinin-1 receptor antagonists and their efficient synthesis"' [Bioorg. Med. Chem. 20 (2012) 5668-5668].

Bioorganic & medicinal chemistry

[No authors listed]
PMID: 25756091
Bioorg Med Chem. 2014 Dec 01;22(23):6726. doi: 10.1016/j.bmc.2014.10.019.

No abstract available.

Cite
Retraction notice to 'Corrigendum to "3-Benzhydryl-4-piperidones as novel neurokinin-1 receptor antagonists and their efficient synthesis"' [Bioorg. Med. Chem. 20 (2012) 5668-5668]. Bioorg Med Chem. 2014;22(23):6726doi: 10.1016/j.bmc.2014.10.019.
(2014). Retraction notice to 'Corrigendum to "3-Benzhydryl-4-piperidones as novel neurokinin-1 receptor antagonists and their efficient synthesis"' [Bioorg. Med. Chem. 20 (2012) 5668-5668]. Bioorganic & medicinal chemistry, 22(23), 6726. https://doi.org/10.1016/j.bmc.2014.10.019
"Retraction notice to 'Corrigendum to "3-Benzhydryl-4-piperidones as novel neurokinin-1 receptor antagonists and their efficient synthesis"' [Bioorg. Med. Chem. 20 (2012) 5668-5668]." Bioorganic & medicinal chemistry vol. 22,23 (2014): 6726. doi: https://doi.org/10.1016/j.bmc.2014.10.019
Retraction notice to 'Corrigendum to "3-Benzhydryl-4-piperidones as novel neurokinin-1 receptor antagonists and their efficient synthesis"' [Bioorg. Med. Chem. 20 (2012) 5668-5668]. Bioorg Med Chem. 2014 Dec 01;22(23):6726. doi: 10.1016/j.bmc.2014.10.019. PMID: 25756091.
Copy Download .nbib Format: NLM
Antitumor Activity of IMC-038525, a Novel Oral Tubulin Polymerization Inhibitor.

Translational oncology

Tuma MC, Malikzay A, Ouyang X, Surguladze D, Fleming J, Mitelman S, Camara M, Finnerty B, Doody J, Chekler EL, Kussie P, Tonra JR.
PMID: 20885894
Transl Oncol. 2010 Oct 01;3(5):318-25. doi: 10.1593/tlo.10160.

Microtubules are a well-validated target for anticancer therapy. Molecules that bind tubulin affect dynamic instability of microtubules causing mitotic arrest of proliferating cells, leading to cell death and tumor growth inhibition. Natural antitubulin agents such as taxanes and Vinca...

Cite
Tuma MC, Malikzay A, Ouyang X, et al. Antitumor Activity of IMC-038525, a Novel Oral Tubulin Polymerization Inhibitor. Transl Oncol. 2010;3(5):318-25doi: 10.1593/tlo.10160.
Tuma, M. C., Malikzay, A., Ouyang, X., Surguladze, D., Fleming, J., Mitelman, S., Camara, M., Finnerty, B., Doody, J., Chekler, E. L., Kussie, P., & Tonra, J. R. (2010). Antitumor Activity of IMC-038525, a Novel Oral Tubulin Polymerization Inhibitor. Translational oncology, 3(5), 318-25. https://doi.org/10.1593/tlo.10160
Tuma, Maria Carolina, et al. "Antitumor Activity of IMC-038525, a Novel Oral Tubulin Polymerization Inhibitor." Translational oncology vol. 3,5 (2010): 318-25. doi: https://doi.org/10.1593/tlo.10160
Tuma MC, Malikzay A, Ouyang X, Surguladze D, Fleming J, Mitelman S, Camara M, Finnerty B, Doody J, Chekler EL, Kussie P, Tonra JR. Antitumor Activity of IMC-038525, a Novel Oral Tubulin Polymerization Inhibitor. Transl Oncol. 2010 Oct 01;3(5):318-25. doi: 10.1593/tlo.10160. PMID: 20885894; PMCID: PMC2935635.
Copy Download .nbib Format: NLM
WITHDRAWN: Synthesis and biological evaluation of some novel Pyrrolo[2, 3-d]pyrimidine derivatives.

Bioorganic & medicinal chemistry letters

Mohamed MS, Kamel R, Fatahala SS.
PMID: 20696577
Bioorg Med Chem Lett. 2010 Aug 07; doi: 10.1016/j.bmcl.2010.06.153. Epub 2010 Aug 07.

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.

Cite
Mohamed MS, Kamel R, Fatahala SS. WITHDRAWN: Synthesis and biological evaluation of some novel Pyrrolo[2, 3-d]pyrimidine derivatives. Bioorg Med Chem Lett. 2010;doi: 10.1016/j.bmcl.2010.06.153.
Mohamed, M. S., Kamel, R., & Fatahala, S. S. (2010). WITHDRAWN: Synthesis and biological evaluation of some novel Pyrrolo[2, 3-d]pyrimidine derivatives. Bioorganic & medicinal chemistry letters, . https://doi.org/10.1016/j.bmcl.2010.06.153
Mohamed, Mosaad S, et al. "WITHDRAWN: Synthesis and biological evaluation of some novel Pyrrolo[2, 3-d]pyrimidine derivatives." Bioorganic & medicinal chemistry letters vol. (2010). doi: https://doi.org/10.1016/j.bmcl.2010.06.153
Mohamed MS, Kamel R, Fatahala SS. WITHDRAWN: Synthesis and biological evaluation of some novel Pyrrolo[2, 3-d]pyrimidine derivatives. Bioorg Med Chem Lett. 2010 Aug 07; doi: 10.1016/j.bmcl.2010.06.153. Epub 2010 Aug 07. PMID: 20696577.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1099 entries